(2026). Pharmacokinetic analysis of nacubactam, a novel β-lactamase inhibitor, co-administered with meropenem in patients with a complicated urinary tract infection. JAC-Antimicrobial Resistance.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Pharmacokinetic Analysis of Nacubactam, a Novel β-lactamase Inhibitor, Co-administered with Meropenem in Patients with a Complicated Urinary Tract Infection."
JAC-Antimicrobial Resistance 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Pharmacokinetic Analysis of Nacubactam, a Novel β-lactamase Inhibitor, Co-administered with Meropenem in Patients with a Complicated Urinary Tract Infection."
JAC-Antimicrobial Resistance, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.